Kymera Therapeutics Inc (KYMR) Insider Trading
- $107,377,856.56
- $165,860,794.87
- April 22, 2026
- Nello Mainolfi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 11, 2023 | Director | 22,110 | $29.89 | Buy | $660,867.90 | |
| Dec. 14, 2022 | Director | 378,966 | $31.37 | Sell | $11,888,163.42 | |
| Dec. 14, 2022 | Major Shareholder | 296,077 | $31.37 | Sell | $9,287,935.49 | |
| Nov. 2, 2022 | Major Shareholder | 96,581 | $30.02 | Sell | $2,899,361.62 | |
| Nov. 2, 2022 | Director | 123,619 | $30.02 | Sell | $3,711,042.38 | |
| Oct. 31, 2022 | Major Shareholder | 94,239 | $30.23 | Sell | $2,848,844.97 | |
| Oct. 31, 2022 | Director | 120,622 | $30.23 | Sell | $3,646,403.06 | |
| Oct. 28, 2022 | Major Shareholder | 71,135 | $30.00 | Sell | $2,134,050.00 | |
| Oct. 28, 2022 | Director | 91,050 | $30.00 | Sell | $2,731,500.00 | |
| Aug. 22, 2022 | Director | 545,525 | $26.00 | Buy | $14,183,650.00 | |
| May 26, 2022 | Director | 224,057 | $14.21 | Buy | $3,183,849.97 | |
| May 20, 2022 | Director | 10,100 | $14.00 | Buy | $141,400.00 | |
| May 5, 2022 | Director | 150,000 | $19.60 | Buy | $2,940,000.00 | |
| Jan. 31, 2022 | Director | 34,408 | $40.70 | Buy | $1,400,405.60 | |
| Jan. 27, 2022 | Director | 95,901 | $38.33 | Buy | $3,675,885.33 | |
| Jan. 24, 2022 | Director | 272,767 | $37.76 | Buy | $10,299,681.92 | |
| Jan. 12, 2022 | CEO | 8,612 | $52.08 | Sell | $448,512.96 | |
| Jan. 12, 2022 | CFO | 15,000 | $51.85 | Sell | $777,750.00 | |
| Jan. 10, 2022 | CEO | 22,465 | $53.26 | Sell | $1,196,485.90 | |
| Dec. 3, 2021 | CFO | 10,000 | $53.56 | Sell | $535,600.00 | |
| Nov. 2, 2021 | Insider | 14,996 | $63.22 | Sell | $948,047.12 | |
| Oct. 11, 2021 | CEO | 6,456 | $53.68 | Sell | $346,558.08 | |
| Oct. 8, 2021 | CEO | 41,544 | $56.76 | Sell | $2,358,037.44 | |
| Sept. 3, 2021 | CFO | 10,000 | $60.12 | Sell | $601,200.00 | |
| Aug. 27, 2021 | Insider | 33,779 | $60.12 | Sell | $2,030,793.48 | |
| Aug. 17, 2021 | Insider | 54,000 | $50.37 | Sell | $2,719,980.00 | |
| Aug. 11, 2021 | Director | 242,133 | $61.00 | Sell | $14,770,113.00 | |
| Aug. 4, 2021 | CEO | 1,037 | $60.03 | Sell | $62,251.11 | |
| Aug. 2, 2021 | CEO | 23,456 | $60.30 | Sell | $1,414,396.80 | |
| July 30, 2021 | CEO | 6,279 | $60.07 | Sell | $377,179.53 | |
| July 28, 2021 | CEO | 3,864 | $60.15 | Sell | $232,419.60 | |
| July 26, 2021 | CEO | 9,015 | $60.15 | Sell | $542,252.25 | |
| July 8, 2021 | CEO | 48,000 | $49.70 | Sell | $2,385,600.00 | |
| July 1, 2021 | Director | 544,166 | $47.00 | Buy | $25,575,802.00 | |
| June 9, 2021 | CEO | 5,752 | $50.02 | Sell | $287,715.04 | |
| June 7, 2021 | CEO | 12,724 | $50.14 | Sell | $637,981.36 | |
| June 3, 2021 | CFO | 10,000 | $46.87 | Sell | $468,700.00 | |
| May 12, 2021 | CEO | 8,245 | $50.05 | Sell | $412,662.25 | |
| April 26, 2021 | CEO | 2,768 | $40.18 | Sell | $111,218.24 | |
| April 23, 2021 | CEO | 680 | $40.01 | Sell | $27,206.80 | |
| April 19, 2021 | CEO | 653 | $40.00 | Sell | $26,120.00 | |
| April 15, 2021 | CEO | 4,940 | $40.29 | Sell | $199,032.60 | |
| April 12, 2021 | CEO | 15,267 | $32.62 | Sell | $498,009.54 | |
| April 9, 2021 | CEO | 22,794 | $33.68 | Sell | $767,701.92 | |
| March 15, 2021 | Insider | 10,305 | $60.17 | Sell | $620,051.85 | |
| March 15, 2021 | CFO | 8,195 | $60.17 | Sell | $493,093.15 | |
| March 12, 2021 | Director | 229,350 | $56.50 | Sell | $12,958,275.00 | |
| March 11, 2021 | CFO | 1,805 | $60.07 | Sell | $108,426.35 | |
| March 11, 2021 | Insider | 4,695 | $60.05 | Sell | $281,934.75 | |
| March 8, 2021 | CFO | 10,000 | $50.65 | Sell | $506,500.00 |
Insiders are both buying and selling Kymera Therapeutics Inc stock.
The insider traders at Kymera Therapeutics Inc are: Nello Mainolfi, Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Jeremy G Chadwick, Jared Gollob, Venture Fund X L.P. Atlas, Jeffrey W. Albers, Ellen Chiniara, Noah Goodman, Richard Chesworth, Pamela Esposito, Bros. Advisors Lp Baker, Bruce N. Jacobs, Joanna Horobin, and Elena Ridloff
The most active insider trader at Kymera Therapeutics Inc is Nello Mainolfi with 22 trades.
Bruce Booth has sold the most Kymera Therapeutics Inc stock with a total value of $87,634,471.76.
Bvf Partners L P/Il has bought the most Kymera Therapeutics Inc stock with a total value of $92,491,204.56.
The most recent insider trade for Kymera Therapeutics Inc was on April 22, 2026.
The single biggest insider buy for Kymera Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $28,842,000.00 on June 30, 2025.
The single biggest insider sell for Kymera Therapeutics Inc was from Bruce Booth with a total value of $17,345,811.60 on July 9, 2024.
